House Dust Mite Allergen Reduction in Bedding: Purotex Impregnated Covers of Bekaert Textiles (Purotex covers)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01997606|
Recruitment Status : Completed
First Posted : November 28, 2013
Last Update Posted : September 26, 2016
Purotex is a textile treatment that uses five 100% natural bacteria or probiotics, selected for their ability to clean up house dust mite allergen along with other allergen types.
- Placebo-controlled: the effect of the Purotex impregnated mattress and pillow covers will be compared to untreated, classical bedding covers (placebo).
- Cross-over design: There will be 2 'treatment' arms. One arm (Arm 1) in which the subjects will first use the Purotex impregnated covers (Set A=Purotex) during 2 months (=period A) and, after a wash out period of 1 month, the untreated covers (set B=placebo) during 2 months (=period B). In the second arm (Arm 2), the subjects will first use the untreated set (set A=placebo) and, after a wash out period the Purotex impregnated covers (set B=Purotex).
- Randomized: The subjects will be randomly assigned to one of the 2 treatment arms.
- Double blind: both the subjects and the investigators will not know to which treatment arm the subjects are assigned.
We want to investigate:
- if there is a reduced concentration of HDM allergen in Purotex covers compared to untreated covers in real life
- if patients with allergic rhinitis to house dust mite use the Purotex covers, they experience an improvement of their quality of life and sleep, and an improvement of their allergic symptoms and global discomfort
|Condition or disease||Intervention/treatment||Phase|
|Allergic Rhinitis||Other: use of Purotex treated bedding covers Other: placebo||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||20 participants|
|Intervention Model:||Crossover Assignment|
|Masking:||Triple (Participant, Investigator, Outcomes Assessor)|
|Official Title:||Cross-over Study of the Impact of Purotex Covers on the Concentration of House Dust Mite Allergen in Bedding and the Quality of Life in Patients With Allergic Rhinitis to House Dust Mite.|
|Study Start Date :||November 2013|
|Actual Primary Completion Date :||September 2016|
|Actual Study Completion Date :||September 2016|
use of Purotex treated bedding covers
Other: use of Purotex treated bedding covers
Purotex is a textile treatment that uses five 100% natural bacteria or probiotics, selected for their ability to clean up house dust mite allergen along with other allergen types. The active probiotics are placed inside of millions of capsules and are introduced during the textile production. These human friendly bacteria remain non-active until friction force is created between the mattress/pillow and the sleeper's body. Under the friction force a small part of the capsules is opened and probiotics become active. They saturate the bacterial capacity of the textile and by doing so, reduce the risk of dust mite allergen development and growth of molds and harmful bacteria. The patients will apply the covers around their mattress and around their pillow. On top of these covers the patients will apply their own fitted sheet and pillowcase (which they will change every 4 weeks).
Placebo Comparator: Placebo
no use of Purotex treated bedding covers
- Change in house dust mite allergen concentration [ Time Frame: every two weeks, starting after randomisation untill completion of the study (5 months after randomisation) ]Concentration of house dust mite allergen in dust collected from the mattress and pillow covers will be measured by using ELISA During the study, the patients will collect dust every 2 weeks (for each cover their will be 5 time points with an interval of 2 weeks on which dust will be collected)
- Change in quality of life [ Time Frame: every week during the course of the study (from baseline untill 5 months after) ]questionnaires: RQLQ, NRQLQ
- change in quality of sleep [ Time Frame: every week during the course of the study (from start till 5 months) ]
- change in control of allergic rhinitis symptoms [ Time Frame: every week during the course of the study (from baseline till month 5) ]questionnaire
- change in global discomfort [ Time Frame: every week during the course of the study (from baseline till month 5) ]global discomfort due to allergic symptoms and discomfort from specific symptoms questionnaire VAS
- change in use of rescue medication [ Time Frame: every week during the course of the study (from baseline till month 5) ]patients will fill out every week a questionnaire about the use of medication for their allergic rhinitis (and asthma)
- change in discomfort during sleep [ Time Frame: every week during the course of the study (from baseline till month 5) ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01997606
|Ghent University Hospital|
|Ghent, Belgium, 9000|